| Literature DB >> 31766156 |
Paula Yagüe1, Nathaly Gonzalez-Quiñonez1, Gemma Fernánez-García1, Sergio Alonso-Fernández1, Angel Manteca1.
Abstract
Reversible protein phosphorylation at serine, threonine and tyrosine is a well-known dynamic post-translational modification with stunning regulatory and signalling functions in eukaryotes. Shotgun phosphoproteomic analyses revealed that this post-translational modification is dramatically lower in bacteria than in eukaryotes. However, Ser/Thr/Tyr phosphorylation is present in all analysed bacteria (24 eubacteria and 1 archaea). It affects central processes, such as primary and secondary metabolism development, sporulation, pathogenicity, virulence or antibiotic resistance. Twenty-nine phosphoprotein orthologues were systematically identified in bacteria: ribosomal proteins, enzymes from glycolysis and gluconeogenesis, elongation factors, cell division proteins, RNA polymerases, ATP synthases and enzymes from the citrate cycle. While Ser/Thr/Tyr phosphorylation exists in bacteria, there is a consensus that histidine phosphorylation is the most abundant protein phosphorylation in prokaryotes. Unfortunately, histidine shotgun phosphorproteomics is not possible due to the reduced phosphohistidine half-life under the acidic pH conditions used in standard LC-MS/MS analysis. However, considering the fast and continuous advances in LC-MS/MS-based phosphoproteomic methodologies, it is expected that further innovations will allow for the study of His phosphoproteomes and a better coverage of bacterial phosphoproteomes. The characterisation of the biological role of bacterial Ser/Thr/Tyr and His phosphorylations might revolutionise our understanding of prokaryotic physiology.Entities:
Keywords: His phosphorylation; LC-MS/MS; Ser/Thr/Tyr phosphorylation; bacteria; differentiation; phosphoproteomics; sporulation
Mesh:
Substances:
Year: 2019 PMID: 31766156 PMCID: PMC6888350 DOI: 10.3390/ijms20225678
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Bacterial Ser/Thr/Tyr phosphoprotemic studies. Abbreviations: n.r., not reported; Ch, chemoheterotrophic.
| Bacterium | Year | pSer (%) | pThr (%) | pTyr (%) | Reference |
|---|---|---|---|---|---|
|
| 2007 | 69.2 | 20.5 | 10.3 | [ |
| 2008 | 68 | 23 | 9 | [ | |
|
| 2008 | 46.5 | 50.6 | 2.7 | [ |
|
| 2009 | 31.2 | 15.1 | 25.8 | [ |
|
| 2009 | 52.8 | 36.1 | 11.1 | [ |
|
| 2009 | 84 | 16 | 0 | [ |
|
| 2010 | 40 | 60 | 0 | [ |
|
| 2010 | 34 | 52 | 14 | [ |
|
| 2010 | 47 | 44 | 9 | [ |
|
| 2010 | n.r. | n.r. | n.r. | [ |
|
| 2011 | n.r. | n.r. | n.r. | [ |
|
| 2011 | 46.8 | 48 | 5.2 | [ |
|
| 2011 | 93 | 43 | 7 | [ |
|
| 2011 | 42.8 | 38.7 | 18.5 | [ |
|
| 2012 | 40 | 50 | 10 | [ |
| 2012 | 63.3 | 16.1 | 19.4 | [ | |
|
| 2012 | 65.3 | 26 | 8.7 | [ |
|
| 2013 | 57 | 36 | 7 | [ |
| 2013 | 43.9 | 42.44 | 13.66 | [ | |
|
| 2013 | 75.9 | 16.7 | 7.4 | [ |
|
| 2014 | n.r. | n.r. | n.r. | [ |
| 2014 | 71.8 | 25.2 | 3.8 | [ | |
| 2014 | 68.9 | 24.1 | 5.2 | [ | |
|
| 2014 | 49 | 24 | 27 | [ |
|
| 2014 | 64 | 31 | 5 | [ |
|
| 2014 | 47 | 45 | 8 | [ |
|
| 2014 | 74.6 | 18.6 | 7.3 | [ |
|
| 2015 | n.r. | n.r. | n.r. | [ |
|
| 2015 | 63 | 28 | 5 | [ |
|
| 2015 | n.r. | n.r. | n.r. | [ |
|
| 2015 | n.r. | n.r. | 22.6 | [ |
| 2015 | n.r. | n.r. | n.r. | [ | |
| 2016 | 47 | 27.6 | 12.4 | [ | |
| 2016 | 41.4 | 29.5 | 17.5 | [ | |
|
| 2017 | 27.79 | 73.97 | 1.24 | [ |
|
| 2017 | 68 | 29 | 3 | [ |
|
| 2018 | n.r | n.r. | n.r. | [ |
|
| 2018 | 50.6 | 47.4 | 2 | [ |
|
| 2019 | 73 | 21 | 6 | [ |
|
| 2019 | 43 | 33 | 23 | [ |
|
|
|
|
|
2DE gel-based bacterial phosphoproteome studies.
| Bacterium | Year | Phosphoproteins | Phosphorylation Sites | Phosphoproteome | Reference |
|---|---|---|---|---|---|
|
| 2011 | 51 | n.r. | Many biological processes | [ |
|
| 2014 | 103 | 76 | Pathogenicity and virulence | [ |
| 2015 | 42 | n.r. | Virulence | [ | |
| 2015 | 34 | n.r. | Virulence | [ |
LC-MS/MS-based nonquantitative bacterial phosphoproteome studies. Abbreviation: Ph, photoheterotrophic.
| Bacterium | Year | Phosphoproteins | Phosphorylation Sites | Phosphoproteome | Reference |
|---|---|---|---|---|---|
|
| 2007 | 78 | 78 | Carbohydrate metabolism | [ |
|
| 2008 | 79 | 81 | Similar to | [ |
|
| 2008 | 63 | 79 | Over-representation of phosphothreonines | [ |
|
| 2009 | 81 | 93 | Capsular biosynthesis | [ |
|
| 2009 | 39 | 61 | Motility, transport and pathogenicity | [ |
|
| 2009 | 59 | 55 | Several biochemical pathways | [ |
|
| 2009 | 26 | 31 | Phosphoproteome in Archaea | [ |
|
| 2010 | 301 | 500 | Several biochemical pathways | [ |
|
| 2010 | 40 | 46 | Housekeeping proteins | [ |
|
| 2010 | 84 | 163 | Carbon/protein/nucleotide metabolisms, cell cycle and division | [ |
|
| 2011 | 112 | 143 | Virulence, translation, carbohydrate metabolism and stress response | [ |
|
| 2011 | 67 | 126 | Virulence | [ |
|
| 2012 | 61 | 107 | Carbon metabolism | [ |
| 2012 | 54 | 63 | Carbon metabolism | [ | |
| 2012 | 42 | 59 | Carbon metabolism | [ | |
|
| 2012 | 48 | 46 | Wide variety of cellular processes | [ |
|
| 2013 | 53 | 67 | Central metabolic pathways and protein/cell envelope biosynthesis | [ |
| 2013 | 245 | 410 | Two-component signalling pathway and photosynthesis | [ | |
| 2014 | 70 | 80 | Pathogenicity and drug resistance | [ | |
| 2014 | 41 | 48 | Several biochemical pathways | [ | |
|
| 2014 | 28 | 59 | Extracellular virulence factors | [ |
|
| 2015 | 77 | 96 | Rhizobial adaptation | [ |
| 2018 | 37 | n.r. | Several biochemical pathways | [ | |
| 2018 | 18 | n.r. | Regulation of toxin generation | [ |
LC-MS/MS-based quantitative bacterial phosphoproteome studies.
| Bacterium | Year | Phosphoproteins | Phosphorylation Sites | Phosphoproteome | Method | Reference |
|---|---|---|---|---|---|---|
|
| 2010 | 27 | 45 | Phosphoproteome changes in different media | SILAC | [ |
|
| 2011 | 127 | 289 | Sporulation factors, transcriptional regulators, protein kinases and other regulatory proteins | Label-free | [ |
|
| 2013 | 133 | 108 | Stationary phase | SILAC | [ |
|
| 2014 | 141 | 177 | Stationary phase | SILAC | [ |
|
| 2014 | 191 | 242 | Purine biosynthesis regulated by PrfA phosphorylation | SILAC | [ |
|
| 2014 | 88 | 109 | Carbon metabolism, environmental stress and protein synthesis affected by phosphorylation | SRM | [ |
|
| 2015 | 71 | n.r. | Phosphorylation varied during development | SRM | [ |
|
| 2015 | 124 | 155 | Spore-specific determinants | Label-free | [ |
| 2015 | 188 | 262 | Increased phosphorylation during nitrogen limitation | Dimethyl | [ | |
| 2016 | 248 | 410 | Antibiotic resistance | Label-free | [ | |
| 2016 | 211 | 285 | Antibiotic resistance | Label-free | [ | |
|
| 2017 | 154 | 224 | Transmembrane proteins | Label-free | [ |
|
| 2017 | 257 | 512 | Virulence | Tandem mass tag (TMT) | [ |
|
| 2018 | 48 | 85 | Regulatory proteins | TMT | [ |
|
| 2019 | 125 | 177 | N2 fixing regulated by phosphorylation | Label-free | [ |
|
| 2019 | 106 | 161 | Divisome proteins phosphorylated by the PknB kinase | Dimethyl | [ |
Figure 1The phosphoprotein orthologues systematically identified in the 38 bacterial phosphoproteomic studies are shown in Table 1, Table 2, Table 3 and Table 4. (a) Phosphoproteins (highlighted in red) are classified by function. The bacteria, in which they were identified, are indicated. (b) Total number of the phosphorylation sites identified for each phosphoprotein orthologue in the 38 analysed bacteria, as well as the number of bacteria, in which a phosphoprotein was detected. Asterisks indicate multiphosphorylated proteins, i.e., these showing more phosphorylation sites than bacteria.